Form 8-K - Current report:
SEC Accession No. 0001193125-20-268017
Filing Date
2020-10-13
Accepted
2020-10-13 08:43:31
Documents
14
Period of Report
2020-10-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23018d8k.htm   iXBRL 8-K 33679
2 EX-99.1 d23018dex991.htm EX-99.1 9891
6 GRAPHIC g23018img1.jpg GRAPHIC 1774
  Complete submission text file 0001193125-20-268017.txt   172134

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20201010.xsd EX-101.SCH 3061
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20201010_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20201010_pre.xml EX-101.PRE 10947
7 EXTRACTED XBRL INSTANCE DOCUMENT d23018d8k_htm.xml XML 3273
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 201234754
SIC: 2834 Pharmaceutical Preparations